ClinicalTrials.Veeva
Menu

Find clinical trials for Heart Disease in Taipei City

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Heart Diseases
Coronary Artery Disease
Cardiovascular Diseases
Heart Failure
Myocardial Ischemia
Coronary Disease
Aortic Valve Stenosis

Heart Disease trials near Taipei City, TWN:

Locations recently updated

ARTEMIS: Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKE

with placebo in reducing the risk of the clinical consequences of AKI (MAKE) at 90 days in adult participants with CKD who undergo non-emergent cardiac...

Enrolling
Chronic Kidney Disease
Cardiac Disease
Drug: Placebo
Drug: Ravulizumab

Phase 3

Alexion Pharmaceuticals
Alexion Pharmaceuticals

Taipei City, Taiwan and 203 other locations

the safety and efficacy of drug-coated balloon (DCB) treatment compared to drug-eluting stenting (DES) in patients with large coronary artery disease...

Enrolling
Coronary Artery Disease
Myocardial Ischemia
Device: SeQuent® Please NEO drug-coated balloon catheter
Device: Current-generation drug-eluting stent
B. Braun
B. Braun

New Taipei City, Taiwan and 18 other locations

whether a medicine called BI 690517 helps people with chronic kidney disease when taken in combination with a study medicine called empaglif ...

Enrolling
Kidney Disease, Chronic
Drug: Placebo matching BI 690517
Drug: Empagliflozin

Phase 3

Boehringer Ingelheim
Boehringer Ingelheim

Taipei, Taiwan and 45 other locations

Status recently updated

The purpose of this study is to establish the safety and effectiveness of pulsed field ablation as a first-line ablation treatment for subjects with...

Enrolling
Active, not recruiting
Persistent Atrial Fibrillation
Device: FARAPULSE™ Pulsed Field Ablation (PFA) System
Drug: Anti-Arrhythmic Drug (AAD): Flecainide, Sotalol, Propafenone, Dofetilide, and Dronedarone
Boston Scientific
Boston Scientific

Taipei, Taiwan and 65 other locations

This study will assess the effect of lowering low-density lipoprotein cholesterol (LDL-C) with evolocumab on major cardiovascular events in adults wi...

Active, not recruiting
Coronary Heart Disease (CHD)
Drug: Evolocumab
Drug: Placebo

Phase 3

Amgen
Amgen

Taipei, Taiwan and 851 other locations

The primary objective of this study is to compare the effect of treatment with olpasiran, to placebo, on the risk for coronary heart disease...

Active, not recruiting
Atherosclerotic Cardiovascular Disease
Drug: Olpasiran
Drug: Placebo

Phase 3

Amgen
Amgen

Taipei, Taiwan and 736 other locations

cardiovascular events (MACE) including coronary heart disease (CHD) death, ischemic stroke, myocardial infarction (MI), acute limb...

Enrolling
Arteriosclerosis
Hypercholesterolaemia
Drug: Placebo
Drug: Enlicitide Decanoate

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Taipei, Taiwan and 657 other locations

and pharmacodynamics of 4D-310 following a single IV administration. The study population is comprised of adult males and females with Fabry Disease...

Enrolling
Fabry Disease
Biological: 4D-310

Phase 1, Phase 2

4D Molecular Therapeutics (4DMT)

Taipei, Taiwan and 3 other locations

The goal of this clinical trial is to see if mirivadelgat will work in patients with Pulmonary Hypertension Associated with Interstitial Lung Disease...

Enrolling
Group 3 Pulmonary Hypertension
Drug: Mirivadelgat
Drug: placebo

Phase 2

Foresee Pharmaceuticals

Taipei City, Taiwan and 6 other locations

for isolated CABG for multi-vessel coronary artery disease and deemed technically suitable for sternotomy CABG as well as for MICS CABG are...

Enrolling
Coronary Artery Disease
Procedure: MICS CABG
Procedure: Conventional CABG
University of Ottawa Heart Institute

Taipei, Taiwan and 12 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems